Literature DB >> 19389539

Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.

Carlos G Wambier, Maria C Foss-Freitas, Renato S Paschoal, Marilia V Tomazini, João C Simão, Milton C Foss, Norma T Foss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19389539     DOI： 10.1016/j.jaad.2008.10.009

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  7 in total

Review 1.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

2.  Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series.

Authors:  Jadwiga B Czajkowska; Brandon Shutty; Susan Zito
Journal:  J Med Case Rep       Date:  2012-01-10

Review 3.  Psoriasis and comorbidities: links and risks.

Authors:  Catherine Ni; Melvin W Chiu
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-04-17

Review 4.  Psoriasis comorbidities: complications and benefits of immunobiological treatment.

Authors:  André Vicente Esteves de Carvalho; Ricardo Romiti; Cacilda da Silva Souza; Renato Soriani Paschoal; Laura de Mattos Milman; Luana Pizarro Meneghello
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

5.  Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis.

Authors:  Patrick R Wood; Evan Manning; Joshua F Baker; Bryant England; Lisa Davis; Grant W Cannon; Ted R Mikuls; Liron Caplan
Journal:  World J Diabetes       Date:  2018-02-15

6.  Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials.

Authors:  Mark C Genovese; Gerd R Burmester; Owen Hagino; Karthinathan Thangavelu; Melitza Iglesias-Rodriguez; Gregory St John; Miguel A González-Gay; Thomas Mandrup-Poulsen; Roy Fleischmann
Journal:  Arthritis Res Ther       Date:  2020-09-09       Impact factor: 5.156

7.  Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes.

Authors:  Emily C Pfeifer; David R Saxon; Robert W Janson
Journal:  J Investig Med High Impact Case Rep       Date:  2017-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.